Key result
Low levels of IgM antibodies against phosphorylcholine were associated with an increased risk of incident myocardial infarction.
Why the study?
Do low levels of IgM antibodies against phosphorylcholine predict the development of acute myocardial infarction?
Case-Control (n=1,350)
Do low levels of IgM antibodies against phosphorylcholine predict the development of acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
Low levels of natural IgM anti-PC are an independent risk marker for the development of myocardial infarction.
OBJECTIVE: Phosphorylcholine (PC) is one important epitope on oxidized low-density lipoprotein that may play an important role by contributing to the atherogenicity of oxidized low-density lipoprotein. IgM antibodies against PC (anti-PC) are present ubiquitously in the population as natural antibodies. We here determine the association between anti-PC and incidence of myocardial infarction (MI). METHODS: We studied 462 incident cases of first events of MI and 888 age-matched and sex-matched controls identified through 13 years of follow-up (1987-1999) of participants in a population-based study from northern Sweden. Relative risks (RRs) with 95% confidence intervals (CIs) of incident MI with adjustments for age, sex, geographical region, hypertension, diabetes, BMI, smoking habits, s-cholesterol and high-sensitivity C-reactive protein were determined. Anti-PC levels were measured by enzyme-linked immunoassay. RESULTS: Low anti-PC values were associated with increased risk of MI. Significant associations were found for values below 26.8 U/ml, corresponding to the lowest 25th percentile, and the highest association was seen below 16.9 U/ml. These results remained almost the same after adjustment for confounding factors (RR crude: 1.56, CI: 1.07-2.28 and RR adjusted: 1.69, CI: 1.09-2.54). CONCLUSION: Low levels of natural IgM anti-PC could play an important role as risk markers for development of MI. Adjustment for common confounders only marginally affected the RR, suggesting that the addition of IgM anti-PC add independent information to the more traditional risk factors.
No takes yet. Share an insight, caveat, or question.
Grönlund et al. (2009) conducted a case-control in acute myocardial infarction (n=1,350). Low levels of IgM antibodies against phosphorylcholine (anti-PC) vs. Higher levels of anti-PC was evaluated on incidence of myocardial infarction (MI) (RR 1.69, 95% CI 1.09-2.54). Low levels of IgM antibodies against phosphorylcholine were associated with an increased risk of incident myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: